m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset
  • Cash
equity trading

Tatva Chintan Pharma Chem Ltd

--(-%)
As on - | -

Volume Analysis

SPOT Pivot Levels

TypeClassicFibonacci
R1 732.23732.2
R2740.92735.53
R3746.33740.92
PP726.82 726.82
S1732.23732.2
S2712.72718.1
S3 704.03712.72

Ratios

ParticularsDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
ROCE-2.78-6.59-
ROE-1.84-4.04-
EPS-0.5-0.470.643.521.99

Peer Comparison

No data available
Scrip NamePriceDaily changeM CapPE Ratio1 Year Return

Corporate Action

  • Board Meetings
  • Dividends
  • Bonus
  • Rights
  • AGM/EGM
  • Credit Rating
29 April 2025
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Tatva Chintan Pharma Chem Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24232GJ1996PLC029894</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.64</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>A-</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CRISIL LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Ishwar Nayi <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: cs@tatvachintan.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Ashok Bothra <br/> Designation: Chief Financial Officer <br/> EmailId: finance@tatvachintan.com</div> </div> <div> <br/> Date: 29/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
29 April 2025
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Tatva Chintan Pharma Chem Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L24232GJ1996PLC029894</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2024-2025</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>FY 2024-25 and FY 2025-26</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>FY 2023-24 and FY 2024-25</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Ishwar Nayi</td></tr><tr><td>Designation :-</td><td>Company Secretary and Compliance Officer</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Ashok Bothra</td></tr> <tr><td>Designation : -</td><td>Chief Financial Officer</td></tr></table><div> <br/> Date: 29/04/2025<br/><br/></div>

About Tatva Chintan Pharma Chem Ltd

Equity img
Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996. The status of the Company converted from Private Limited into a Public Limited Company effective from 27 January 2021 and the name of Company also changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'. The Company is promoted by Mr. C...
ISIN :INE0GK401011
  • Registered Office

    No 502/17 GIDC Estate,Ankleshwar

    Contact number

    + +91-75730-46951/46952
  • Registrars

    MUFG Intime India Pvt Ltd
    C-101 247 Park L B S Marg Vikhroli West Mumbai-400083

    Contact number

    + 91-22-49186000
  • Management

    Chintan Nitinkumar Shah (Chairman)

    Chintan Nitinkumar Shah (Director)

expAppScreen

Explore m.Stock AppInstant margin | Real-time charts | Quick order placements

Scan QR Code
qcScan
OR
Get it on
img113GPlayimg113Apple

FAQs

What is the share price of Tatva Chintan Pharma Chem Ltd today on the BSE?

The share price of Tatva Chintan Pharma Chem Ltd on the BSE is - as on -

What is ‘Today’s High & Low’ share prices of Tatva Chintan Pharma Chem Ltd on the BSE?

Today’s High share price of Tatva Chintan Pharma Chem Ltd on the BSE is - as on -
Today’s Low share price of Tatva Chintan Pharma Chem Ltd on the BSE is - as on -

What is the market cap of Tatva Chintan Pharma Chem Ltd today?

The market cap of Tatva Chintan Pharma Chem Ltd is - Cr as on -

What price did Tatva Chintan Pharma Chem Ltd shares open on BSE today?

Tatva Chintan Pharma Chem Ltd opened at - on BSE as on -

What was yesterday 's closing price for Tatva Chintan Pharma Chem Ltd shares on the BSE?

Tatva Chintan Pharma Chem Ltd closed at - on BSE as on -